Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05822141 · ClinicalTrials.gov registry record · NA
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
A NA study of Cold Exposure, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05822141: Recruiting NA study of Cold Exposure, sponsored by Indiana University.
NCT05822141 is a NA study of Cold Exposure that is actively recruiting participants, run by Indiana University. The registered enrollment target is 30 participants, below the 56-participant average among 3 other Cold Exposure trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05822141, a NA study of Cold Exposure, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will assess the whether fish oil supplementation can modulate brown fat activation, shivering, thermal comfort and skin blood flow during cold exposure.
Primary Outcome
Core body temperature will be continuously measured by a rectal probe
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Fish Oil
Study Locations (1)
Indiana
- Human Perfromance Lab, Indiana University - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT05822141 shows while recruiting
NCT05822141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 56-participant average among 3 other Cold Exposure trials with a reported enrollment target (46% lower).
The record links to 1 condition, with Cold Exposure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05822141 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05822141 about?
NCT05822141 is a clinical study titled "Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure". This clinical trial will assess the whether fish oil supplementation can modulate brown fat activation, shivering, thermal comfort and skin blood flow during cold exposure.
What is the current status of trial NCT05822141?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-06-12. Estimated completion is 2025-12.
What conditions does trial NCT05822141 study?
This clinical trial studies the following conditions: Cold Exposure.
What interventions are being tested in trial NCT05822141?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Fish Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05822141?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05822141 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cold Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI